Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 5Terminated 2Recruiting 2Unknown 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 18Recurrence 16Pancreatic Neoplasms 16Multiple Myeloma 15Prostatic Neoplasms 13Advanced Solid Tumors 12Carcinoma, Hepatocellular 11Stomach Neoplasms 10Leukemia, Myeloid, Acute 10Advanced Solid Tumor 10Ovarian Neoplasms 9Triple Negative Breast Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Uterine Cervical Neoplasms 4Lymphoma 4

Interventions

pembrolizumab 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Gallbladder Neoplasms × Clear all
NCT07269158 2025-12-08

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Yonsei University

Phase 1/2 Not yet recruiting
160 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡